Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis

Bruce K. Rubin, Richard C. Hubbard, Steven Shak, Ronald Crystal

Research output: Contribution to journalLetter

7 Citations (Scopus)

Abstract

To the Editor: The preliminary report by Hubbard et al. (March 19 issue)1 on the use of aerosolized recombinant human deoxyribonuclease I (rhDNase) in the treatment of cystic fibrosis is intriguing, but the authors appear to have concluded that rhDNase reduced sputum viscoelasticity in vivo without support from the data. It has been demonstrated that sputum from patients with cystic fibrosis is equally or less viscoelastic than sputum from patients with chronic bronchitis or dogs that have undergone tracheostomy.2 3 4 5 A reference cited by the authors to support the contention that sputum in cystic fibrosis is hyperviscous because of its DNA…

Original languageEnglish
Number of pages1
JournalNew England Journal of Medicine
Volume327
Issue number8
DOIs
Publication statusPublished - 20 Aug 1992
Externally publishedYes

Fingerprint

Sputum
Cystic Fibrosis
Chronic Bronchitis
Therapeutics
Dogs
dornase alfa
DNA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis. / Rubin, Bruce K.; Hubbard, Richard C.; Shak, Steven; Crystal, Ronald.

In: New England Journal of Medicine, Vol. 327, No. 8, 20.08.1992.

Research output: Contribution to journalLetter

@article{dc00f138c5bf41d0acdad78321e4518e,
title = "Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis",
abstract = "To the Editor: The preliminary report by Hubbard et al. (March 19 issue)1 on the use of aerosolized recombinant human deoxyribonuclease I (rhDNase) in the treatment of cystic fibrosis is intriguing, but the authors appear to have concluded that rhDNase reduced sputum viscoelasticity in vivo without support from the data. It has been demonstrated that sputum from patients with cystic fibrosis is equally or less viscoelastic than sputum from patients with chronic bronchitis or dogs that have undergone tracheostomy.2 3 4 5 A reference cited by the authors to support the contention that sputum in cystic fibrosis is hyperviscous because of its DNA…",
author = "Rubin, {Bruce K.} and Hubbard, {Richard C.} and Steven Shak and Ronald Crystal",
year = "1992",
month = "8",
day = "20",
doi = "10.1056/NEJM199208203270820",
language = "English",
volume = "327",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "8",

}

TY - JOUR

T1 - Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis

AU - Rubin, Bruce K.

AU - Hubbard, Richard C.

AU - Shak, Steven

AU - Crystal, Ronald

PY - 1992/8/20

Y1 - 1992/8/20

N2 - To the Editor: The preliminary report by Hubbard et al. (March 19 issue)1 on the use of aerosolized recombinant human deoxyribonuclease I (rhDNase) in the treatment of cystic fibrosis is intriguing, but the authors appear to have concluded that rhDNase reduced sputum viscoelasticity in vivo without support from the data. It has been demonstrated that sputum from patients with cystic fibrosis is equally or less viscoelastic than sputum from patients with chronic bronchitis or dogs that have undergone tracheostomy.2 3 4 5 A reference cited by the authors to support the contention that sputum in cystic fibrosis is hyperviscous because of its DNA…

AB - To the Editor: The preliminary report by Hubbard et al. (March 19 issue)1 on the use of aerosolized recombinant human deoxyribonuclease I (rhDNase) in the treatment of cystic fibrosis is intriguing, but the authors appear to have concluded that rhDNase reduced sputum viscoelasticity in vivo without support from the data. It has been demonstrated that sputum from patients with cystic fibrosis is equally or less viscoelastic than sputum from patients with chronic bronchitis or dogs that have undergone tracheostomy.2 3 4 5 A reference cited by the authors to support the contention that sputum in cystic fibrosis is hyperviscous because of its DNA…

UR - http://www.scopus.com/inward/record.url?scp=0026736076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026736076&partnerID=8YFLogxK

U2 - 10.1056/NEJM199208203270820

DO - 10.1056/NEJM199208203270820

M3 - Letter

VL - 327

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 8

ER -